Literature DB >> 14707303

Oxygen extraction fraction and acetazolamide reactivity in symptomatic carotid artery disease.

H Yamauchi1, H Okazawa, Y Kishibe, K Sugimoto, M Takahashi.   

Abstract

OBJECTIVE: It has been proposed that cerebral blood flow (CBF) response to acetazolamide may be reduced according to the degree of autoregulatory vasodilation in regions with normal oxygen extraction fraction (OEF), whereas the CBF response may be absent in regions with increased OEF where vasodilation may be maximal in response to reduced perfusion pressure. The objective of this study was to test this hypothesis.
METHODS: Positron emission tomography (PET) was used to study 30 symptomatic patients with carotid artery steno-occlusive lesions. CBF at baseline and 10 minutes after an intravenous injection of 1 g acetazolamide was measured. The correlation between the change in CBF during acetazolamide administration and the baseline value of OEF in the affected hemisphere was examined.
RESULTS: The baseline OEF value was inversely and non-linearly correlated with the percentage change in CBF during acetazolamide administration (R(2) = 0.25, p = 0.02). There was an upward trend of OEF with diminishing acetazolamide response below a critical level around zero response. Acetazolamide response less than 6.65% over baseline (sensitivity 100%, specificity 89%, positive predictive value 50%, negative predictive value 100%) was established as most helpful in predicting abnormally high OEF.
CONCLUSIONS: The inverse, non-linear relationship between OEF and CBF response to acetazolamide suggests that these two measurements may not identify haemodynamic impairment in the same patients.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14707303      PMCID: PMC1757491     

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  31 in total

1.  Reduced blood flow response to acetazolamide reflects pre-existing vasodilation and decreased oxygen metabolism in major cerebral arterial occlusive disease.

Authors:  Hiroshi Yamauchi; Hidehiko Okazawa; Yoshihiko Kishibe; Kanji Sugimoto; Masaaki Takahashi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2002-08-06       Impact factor: 9.236

2.  Local brain haemodynamics and oxygen metabolism in cerebrovascular disease. Positron emission tomography.

Authors:  G Sette; J C Baron; B Mazoyer; M Levasseur; S Pappata; C Crouzel
Journal:  Brain       Date:  1989-08       Impact factor: 13.501

Review 3.  Diaschisis.

Authors:  D M Feeney; J C Baron
Journal:  Stroke       Date:  1986 Sep-Oct       Impact factor: 7.914

4.  Assessment of cerebral haemodynamic reserve: correlation between PET parameters and CO2 reactivity measured by the intravenous 133 xenon injection technique.

Authors:  S Herold; M M Brown; R S Frackowiak; A O Mansfield; D J Thomas; J Marshall
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-08       Impact factor: 10.154

5.  Correction for the presence of intravascular oxygen-15 in the steady-state technique for measuring regional oxygen extraction ratio in the brain: 1. Description of the method.

Authors:  A A Lammertsma; T Jones
Journal:  J Cereb Blood Flow Metab       Date:  1983-12       Impact factor: 6.200

6.  Brain blood flow measured with intravenous H2(15)O. I. Theory and error analysis.

Authors:  P Herscovitch; J Markham; M E Raichle
Journal:  J Nucl Med       Date:  1983-09       Impact factor: 10.057

7.  Brain blood flow measured with intravenous H2(15)O. II. Implementation and validation.

Authors:  M E Raichle; W R Martin; P Herscovitch; M A Mintun; J Markham
Journal:  J Nucl Med       Date:  1983-09       Impact factor: 10.057

8.  Severely impaired cerebrovascular reactivity predicts stroke and TIA risk in patients with carotid artery stenosis and occlusion.

Authors:  H Markus; M Cullinane
Journal:  Brain       Date:  2001-03       Impact factor: 13.501

9.  Reversal of focal "misery-perfusion syndrome" by extra-intracranial arterial bypass in hemodynamic cerebral ischemia. A case study with 15O positron emission tomography.

Authors:  J C Baron; M G Bousser; A Rey; A Guillard; D Comar; P Castaigne
Journal:  Stroke       Date:  1981 Jul-Aug       Impact factor: 7.914

10.  Quantitative measurement of regional cerebral blood flow and oxygen metabolism in man using 15O and positron emission tomography: theory, procedure, and normal values.

Authors:  R S Frackowiak; G L Lenzi; T Jones; J D Heather
Journal:  J Comput Assist Tomogr       Date:  1980-12       Impact factor: 1.826

View more
  4 in total

1.  Can the detection of misery perfusion in chronic cerebrovascular disease be based on reductions in baseline CBF and vasoreactivity?

Authors:  Hidehiko Okazawa; Tatsuro Tsuchida; Masato Kobayashi; Yoshikazu Arai; Marco Pagani; Makoto Isozaki; Yoshiharu Yonekura
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-08-08       Impact factor: 9.236

2.  Transoral ultrasonographic evaluation of carotid flow in predicting cerebral hemodynamics after carotid endarterectomy.

Authors:  M Kamouchi; K Kishikawa; Y Okada; T Inoue; K Toyoda; S Ibayashi; M Iida
Journal:  AJNR Am J Neuroradiol       Date:  2006 Jun-Jul       Impact factor: 3.825

3.  Hemodynamic mechanisms underlying elevated oxygen extraction fraction (OEF) in moyamoya and sickle cell anemia patients.

Authors:  Jennifer M Watchmaker; Meher R Juttukonda; Larry T Davis; Allison O Scott; Carlos C Faraco; Melissa C Gindville; Lori C Jordan; Petrice M Cogswell; Angela L Jefferson; Howard S Kirshner; Manus J Donahue
Journal:  J Cereb Blood Flow Metab       Date:  2016-12-28       Impact factor: 6.200

4.  Detection of misery perfusion in the cerebral hemisphere with chronic unilateral major cerebral artery steno-occlusive disease using crossed cerebellar hypoperfusion: comparison of brain SPECT and PET imaging.

Authors:  Yoshiyasu Matsumoto; Kuniaki Ogasawara; Hideo Saito; Kazunori Terasaki; Yoshihiro Takahashi; Yasushi Ogasawara; Masakazu Kobayashi; Kenji Yoshida; Takaaki Beppu; Yoshitaka Kubo; Shunrou Fujiwara; Eiki Tsushima; Akira Ogawa
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-06-06       Impact factor: 9.236

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.